Melanoma Treatments: Breakthroughs for Multiple Cancers — for Real and Right Now
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 July 2017 In Science, Treatment
While 2014 and 2015 offered a whirlwind of good news related to new melanoma treatments from immune to targeted therapy, since then, it’s been a bit quieter in melanoma. Although there has been exceptional news in regard to other cancers. Why is that, and what are the latest breakthroughs?
Sunscreen Laws may Hinder Protecting Children from Exposure
With the launch of summer comes conventional discussion around ranking sunscreens, and chatter between the experts to parse what should be considered in choosing the most effective among them. It’s also a key conversation among parents heading into the season with an eye on protecting their children from sun exposure. Yet, something remaining a central concern among those parents is the public policy surrounding use of sunscreen in schools.
Strides and Obstacles in Melanoma Research Spotlight on Martin McMahon, PhD
Like so many in the melanoma research field, Martin McMahon, PhD, Huntsman Cancer Institute’s senior director of pre-clinical translation and Professor at the University of Utah, entered the melanoma field by accident.
Melanoma Prevention: The Latest Advances & Future Directions
During my interview with Susan Swetter, MD, Professor of Dermatology,
Stanford University and VA Palo Alto, at the Melanoma Research Alliance Ninth Annual Scientific Retreat in Washington, DC, I inquired about the Panel Discussion she was part of titled: News from the field: What’s going well and what remains to be done?
8th Annual Scientific Retreat Recap
The end of February was a momentous one for the MRA team and all the folks in the melanoma community. We hosted our 8th Annual Scientific Retreat in Washington, DC, and they truly just seem to get better and better. The Retreat serves two main roles for those invited participants.
Expanded Access Programs: A Time of Amazement in Melanoma
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 August 2014 In Science, Treatment
For those of you keeping a close eye on the field of melanoma treatments, you know that we find ourselves living in a simply amazing period of opportunity and innovation—even though there is still a long way to go.
The First FDA Approval of Two Melanoma Therapies in Combination
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 January 2014 In News
You may have heard this from other sources already, but we want to take a minute and explain why we’re so excited at MRA by some recent news. This week, GlaxoSmithKline announced that it had received approval from the U.S. Food and Drug Administration (FDA) of a combination treatment for melanoma.
Looking Back on 2013
23 December 2013 In News
From everyone here at the Melanoma Research Alliance (MRA), we wish you a healthy and happy holiday season and extend our heartfelt gratitude for an amazing year of progress and collaboration. We are so thankful for the tremendous support we received this year from so many people who share our...
New Melanoma Therapies Approved
31 May 2013 In News
These are the best types of posts to write: On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine which patients' tumors carry the specific genetic mutations the treatments target.